Latest
Kanvas Biosciences Raises $48M in Series A to Advance Microbiome-Based Cancer TherapiesKanvas Biosciences Raises $48M in Series A to Advance Microbiome-Based Cancer Therapies|Woman Owned NYC and Pulse NYC Bring Women Leaders to the Center of AI Week New York 2026Woman Owned NYC and Pulse NYC Bring Women Leaders to the Center of AI Week New York 2026|SYPartners and Pulse NYC Bring Radical Imagination Studio to #AIWeekNY for AI-Era Leadership ConversationsSYPartners and Pulse NYC Bring Radical Imagination Studio to #AIWeekNY for AI-Era Leadership Conversations|AI Week NY: Magic EdTech’s UX Challenge Puts Trust at the Center of Product DesignAI Week NY: Magic EdTech’s UX Challenge Puts Trust at the Center of Product Design|Tessera Labs Raises $60M in Series A to Automate Enterprise System TransformationsTessera Labs Raises $60M in Series A to Automate Enterprise System Transformations|InstaSwitch Raises $4.7M in Seed Funding to Streamline Business Banking Account ActivationInstaSwitch Raises $4.7M in Seed Funding to Streamline Business Banking Account Activation|Scout Space Raises Up to $18M in Series A to Expand Space Domain Awareness InfrastructureScout Space Raises Up to $18M in Series A to Expand Space Domain Awareness Infrastructure|4D Path Secures Strategic Financing to Advance Physics-Based Cancer Prediction Platform4D Path Secures Strategic Financing to Advance Physics-Based Cancer Prediction Platform|Vastian Secures Strategic Investment from Bregal Sagemount to Expand Healthcare Compliance PlatformVastian Secures Strategic Investment from Bregal Sagemount to Expand Healthcare Compliance Platform|Altara Raises $7M in Seed Funding to Build AI Platform for Industrial Data IntelligenceAltara Raises $7M in Seed Funding to Build AI Platform for Industrial Data Intelligence|Kanvas Biosciences Raises $48M in Series A to Advance Microbiome-Based Cancer TherapiesKanvas Biosciences Raises $48M in Series A to Advance Microbiome-Based Cancer Therapies|Woman Owned NYC and Pulse NYC Bring Women Leaders to the Center of AI Week New York 2026Woman Owned NYC and Pulse NYC Bring Women Leaders to the Center of AI Week New York 2026|SYPartners and Pulse NYC Bring Radical Imagination Studio to #AIWeekNY for AI-Era Leadership ConversationsSYPartners and Pulse NYC Bring Radical Imagination Studio to #AIWeekNY for AI-Era Leadership Conversations|AI Week NY: Magic EdTech’s UX Challenge Puts Trust at the Center of Product DesignAI Week NY: Magic EdTech’s UX Challenge Puts Trust at the Center of Product Design|Tessera Labs Raises $60M in Series A to Automate Enterprise System TransformationsTessera Labs Raises $60M in Series A to Automate Enterprise System Transformations|InstaSwitch Raises $4.7M in Seed Funding to Streamline Business Banking Account ActivationInstaSwitch Raises $4.7M in Seed Funding to Streamline Business Banking Account Activation|Scout Space Raises Up to $18M in Series A to Expand Space Domain Awareness InfrastructureScout Space Raises Up to $18M in Series A to Expand Space Domain Awareness Infrastructure|4D Path Secures Strategic Financing to Advance Physics-Based Cancer Prediction Platform4D Path Secures Strategic Financing to Advance Physics-Based Cancer Prediction Platform|Vastian Secures Strategic Investment from Bregal Sagemount to Expand Healthcare Compliance PlatformVastian Secures Strategic Investment from Bregal Sagemount to Expand Healthcare Compliance Platform|Altara Raises $7M in Seed Funding to Build AI Platform for Industrial Data IntelligenceAltara Raises $7M in Seed Funding to Build AI Platform for Industrial Data Intelligence
Back to articles

Pillr Health Secures Investment from Water Street Healthcare Partners

Pillr Health just did what smart operators do when a system gets louder, messier, and more expensive at scale. They leaned into the pressure and built infrastructure instead of theater. Water Street...

Pillr Health just did what smart operators do when a system gets louder, messier, and more expensive at scale. They leaned into the pressure and built infrastructure instead of theater. Water Street Healthcare Partners stepping in is not speculative capital chasing headlines. It is disciplined money following signal. When a $66B program keeps growing at 24% YoY while oversight tightens and margin expectations rise, the winners are never the loudest. They are the ones that make complexity survivable.

Pillr Health came together in Feb 2025 from RxStrategies, Hudson Headwaters 340B, and RPH Innovations, three groups that understood the 340B program from completely different vantage points and realized fragmentation was the hidden tax. RxStrategies brought the tech spine. Hudson Headwaters brought real-world safety-net execution. RPH Innovations brought operational command. Boca Raton became the meeting point, but the real convergence happened at the workflow level where compliance, revenue, and care collide daily.

Highbridge is where the weight gets carried. Split billing. Mixed-use inventory control. Real-time prescription visibility. Audit readiness without panic. This is not software designed to impress demos. It is built to survive HRSA scrutiny and boardroom questions in the same week. When Sam's Club Pharmacy selected Highbridge as the foundation for its first-ever 340B participation starting Jan 1, 2026, that was not experimentation. National retail does not place $66B-adjacent bets on fragile plumbing.

300+ hospitals and health systems already run through Pillr Health across 20+ states. That matters when contract pharmacy relationships have grown from 42K to more than 229K in under a decade. At that scale, mistakes compound fast. Compliance stops being a checklist and becomes an operating philosophy. Layer in specialty pharmacy and outpatient retail expansion and suddenly Pillr is not a name. It is a structural element.

Leadership shows up in the details. Skip Devanny did not discover 340B late. From Cerner to Talyst to RxStrategies and now Pillr Health, this has been a long build. Clay Callicoat brings PE-grade financial discipline shaped by acquisitions and integrations. Mickey Price carries 30+ years of pharmacy ops credibility. David Wanless keeps the tech honest. Fenton Markevich brings institutional memory and zero tolerance for sloppy execution. This is a team fluent in both margin math and mission pressure.

Water Street Healthcare Partners knows this terrain. Max Mishkin and Patrick Teyro are not buying novelty. They are backing infrastructure that lets providers fund care under shrinking budgets and rising audits. Organic build. Strategic M&A. National reach. Pressure applied with intent.

The $340B landscape is not simplifying. Specialty pharmacy is a $695.4B global engine growing at 7.5% CAGR. Providers are being asked to do more with less while being watched closer than ever. Pillr Health is building the supports that let the system carry that weight longer, quieter, and with fewer fractures. The interesting part is not that this works today. It is how much room there is left to push it tomorrow.